Breaking News

Axis Biotec, PlantForm Enter Bio Mfg. Pact

Plans call for construction of an innovative tobacco-based biopharma expression and pilot manufacturing facility in Brazil

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Construction will begin this summer on a state-of-the-art biopharmaceutical lab and pilot production facility in Rio de Janeiro that will support the development of key biosimilar and biobetter protein drugs for the Brazilian market, through a joint venture between Brazil-based Axis Biotec Brasil and Canadian biotech company PlantForm Corporation. The new laboratory and manufacturing facility, supported by funding from Finep (Brazilian Funding Agency for Studies and Projects), is expected to ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters